Skip to main content
    O

    Oncolytics Biotech Inc (ONCY)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.34
    -0.03 (-8.14%)

    Market Cap: $48.51M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Oncolytics Biotech Inc (ONCY) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Oncolytics Biotech are Cardiff Oncology (CRDF), OS Therapies (OSTX) and Connect Biopharma Holdings (CNTB). By market cap, Oncolytics Biotech ranks 5th of the 13 companies on this page; Tiziana Life Sciences (TLSA) is the largest at $72.53M.

    Peer Comparison

    ONCY's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Oncolytics Biotech (ONCY)$48.51MN/AN/A0.0%N/A0.0%0.00%
    Cardiff Oncology Inc (CRDF)$56.49MN/A115.5x0.0%N/A-14.1%0.00%
    OS Therapies Incorporated (OSTX)$34.87MN/AN/A0.0%218.0%0.0%0.00%
    Connect Biopharma Holdings Ltd (CNTB)$42.65MN/A13.6x0.0%N/A5667.0%0.00%
    Champions Oncology Inc (CSBR)$65.49MN/A1.0x-1.9%N/A8.8%0.00%
    XBiotech Inc (XBIT)$59.76MN/AN/A0.0%N/A-93.3%0.00%
    Mural Oncology plc (MURA)$35.38MN/AN/A0.0%-173.6%0.0%0.00%
    Instil Bio Inc. (TIL)$41.23MN/AN/A0.0%-11.9%0.0%0.00%
    Plus Therapeutics Inc (PSTV)$26.64MN/A2.0x-230.2%-827.8%-2.9%0.00%
    Werewolf Therapeutics Inc (HOWL)$47.64MN/A2.3x-164.8%N/A-100.0%0.00%
    Tiziana Life Sciences Ltd (TLSA)$72.53MN/AN/A0.0%N/A0.0%0.00%
    ImageneBio, Inc. (IMA)$43.22MN/A68.5x0.0%N/A0.0%0.00%
    Telomir Pharmaceuticals, Inc. Common Stock (TELO)$36.15MN/AN/A0.0%N/A0.0%0.00%
    Peer median$42.93MN/A8.0x0.0%-92.8%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Oncolytics Biotech, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Cardiff Oncology Inc (CRDF)
    Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer.
    CRDF competitors
    OS Therapies Incorporated (OSTX)
    OS Therapies Incorporated is a pioneering biopharmaceutical company committed to developing innovative treatments for unmet medical needs...
    OSTX competitors
    Connect Biopharma Holdings Ltd (CNTB)
    Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, is focused on the discovery and development of immune modulators...
    CNTB competitors
    Champions Oncology Inc (CSBR)
    Champions Oncology, Inc. develops and sells technology products and solutions to customize the development and use of cancer drugs in the United States.
    CSBR competitors
    XBiotech Inc (XBIT)
    XBiotech Inc., a biopharmaceutical company, discovers, develops and markets True Human monoclonal antibodies for the treatment of various diseases.
    XBIT competitors
    Mural Oncology plc (MURA)
    Mural Oncology plc is a pioneering biotechnology company dedicated to developing targeted therapies for solid tumors...
    Instil Bio Inc. (TIL)
    Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer patients.
    TIL competitors
    Plus Therapeutics Inc (PSTV)
    Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing...
    PSTV competitors
    Werewolf Therapeutics Inc (HOWL)
    Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapies designed to boost the body's immune system for the treatment of cancer.
    HOWL competitors
    Tiziana Life Sciences Ltd (TLSA)
    Tiziana Life Sciences Plc, a clinical-stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat...
    ImageneBio, Inc. (IMA)
    ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases.
    IMA competitors
    Telomir Pharmaceuticals, Inc. Common Stock (TELO)
    Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human...
    TELO competitors

    Frequently Asked Questions About ONCY

    Who are Oncolytics Biotech's main competitors?

    The companies most similar to Oncolytics Biotech include Cardiff Oncology (CRDF), OS Therapies (OSTX), Connect Biopharma Holdings (CNTB), Champions Oncology (CSBR) and XBiotech (XBIT), listed from the closest match.

    Who is Oncolytics Biotech's biggest competitor?

    Tiziana Life Sciences (TLSA) is the largest of the similar companies at $72.53M; Cardiff Oncology (CRDF) is the closest match by business profile, size, sector and industry.

    How does ONCY stock compare with its competitors?

    ONCY's net margin is 0.0% against a peer median of 0.0%.

    Which of Oncolytics Biotech's competitors pays a higher dividend?

    Oncolytics Biotech pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Oncolytics Biotech bigger than its competitors?

    No. Oncolytics Biotech is 5th by market cap among the 13 companies on this page; the largest is Tiziana Life Sciences (TLSA) at $72.53M.